Very-Low-Dose Nivolumab in Patients With Impaired Performance Status: A Real-World Experience From India (ESMO-IO 2026) - Oct 25, 2026 - Abstract #202P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • Real-world • Real-world evidence • Oncology
|
|
Saurabh Tiwari; Deba D. Biswal; Bhawna Sirohi; Archana J; Rachna Sahu
|